Mitigating Infectious morbidity and Growth deficits in HIV-exposed uninfected infanTs with human Milk Oligosaccharide (MIGH-T MO): a randomised trial protocol

Shivakoti, R., Slogrove, A. L., Laughton, B., Shafiq, M., Schoeman, E., Glashoff, R. H., Leu, C.-S., Wang, S., Bode, L., Aldrovandi, G., & Kuhn, L. (2022). Mitigating Infectious morbidity and Growth deficits in HIV-exposed uninfected infanTs with human Milk Oligosaccharide (MIGH-T MO): a randomised trial protocol. BMJ Open, 12(12), e069116. https://doi.org/10.1136/bmjopen-2022-069116

Authors:

Rupak Shivakoti

Amy L Slogrove

Barbara Laughton

Mehr Shafiq

Elisma Schoeman

Richard H Glashoff

Cheng-Shiun Leu

Shuang Wang

Lars Bode

Grace Aldrovandi

Louise Kuhn